METHYLPHENIDATE (A Background Paper)
U.S. Department of Justice Drug Enforcement Administration METHYLPHENIDATE (A Background Paper) October 1995 Drug and Chemical Evaluation Section Office of Diversion Control Summary Methylphenidate is a Schedule II stimulant which is structurally and pharmacologically similar to the amphetamines. It is indicated for the treatment of Attention Deficit/Hyperactivity Disorders (ADHD) and narcolepsy. Approximately 85 to 90 percent of all prescriptions for methylphenidate are written for young children and […]